DR.MAX secures contract for Antineoplastic and immunomodulating agents - framework agreement for the supply of medicines from the group; ANTINEOPLASICS AND IMMUNOMODULATORS - SACITUZUMAB GOVITECAN POWDER PT CONC PT SOL PERF 200 MG

Romania, July 6 -- Romania based DR.MAX has secured contract from Operator SEAP for Antineoplastic and immunomodulating agents - framework agreement for the supply of medicines from the group; ANTINEOPLASICS AND IMMUNOMODULATORS - SACITUZUMAB GOVITECAN POWDER PT CONC PT SOL PERF 200 MG . The value of the contract is worth 69874.95 RON .

Published by HT Digital Content Services with permission from Pivotal Sources....